Federal regulators on Wednesday agreed to allow Schering-Plough Corp. to begin selling its allergy treatment Claritin without a prescription, a US Food and Drug Administration spokeswoman said.
Schering-Plough said the approval applies to all five formulations of Claritin.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!